Principles of initial experimental drug abuse liability assessment in humans
- 2 May 2003
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 70 (3) , S41-S54
- https://doi.org/10.1016/s0376-8716(03)00098-x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioidsDrug and Alcohol Dependence, 1999
- Validation of the multiple-choice procedure for investigating drug reinforcement in humans.Experimental and Clinical Psychopharmacology, 1996
- Comparative Abuse Liability of Sertraline, Alprazolam, and Dextroamphetamine in HumansJournal of Clinical Psychopharmacology, 1995
- Alprazolam and DN-2327 (Pazinaclone) in humans: Psychomotor, memory, subjective, and reinforcing effects.Experimental and Clinical Psychopharmacology, 1995
- Buspirone and lorazepam abuse liability in humansBehavioural Pharmacology, 1993
- Multiple-choice procedureBehavioural Pharmacology, 1993
- Behavioral pharmacology of abecarnil in baboonsBehavioural Pharmacology, 1992
- Human drug abuse liability assessment: opioids and analgesicsBritish Journal of Addiction, 1991
- Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendationsBritish Journal of Addiction, 1991
- Individual differences in the reinforcing and subjective effects of amphetamine and diazepamDrug and Alcohol Dependence, 1986